May, 02 2016, 08:30am EDT

For Immediate Release
Contact:
Dutch media please contact Greenpeace Netherlands, +31 (0)6 21 29 68 95, persvoorlichting@greenpeace.nl
Brussels media please contact Greenpeace EU press desk, +32 (0)2 274 1911, pressdesk.eu@greenpeace.org
International media please contact Greenpeace International press desk (24 hours), +31 (0)20 718 2470, pressdesk.int@greenpeace.org
Greenpeace Netherlands Releases TTIP Documents
AMSTERDAM
Today Greenpeace Netherlands releases secret documents of the EU-US TTIP negotiations. On www.ttip-leaks.org the documents will be made available for everyone to read, because democracy needs transparency.
"These documents make clear the scale and scope of the trade citizens of the United States and the European Union are being asked to make in pursuit of corporate profits. It is time for the negotiations to stop, and the debate to begin.
Should we be able to act when we have reasonable grounds to believe our health and wellbeing is at risk, or must we wait until the damage is done?
Were our governments serious in Paris when they said they would do what was necessary to protect the planet, and keep climate change under 1.5 degrees?
Environmental protection should not be seen as a barrier to trade, but as a safeguard for our health, and the health of future generations.
We call on citizens, civil society, politicians and businesses to engage in this debate openly and without fear. We call on the negotiators to release the latest, complete text to facilitate that discussion, and we ask that the negotiations be stopped until these questions, and many more have been answered. Until we can fully engage in a debate about the standards we and our planet need and want" - Sylvia Borren, Executive Director Greenpeace Netherlands.
Which documents are we releasing?
The documents that Greenpeace Netherlands has released comprise about half of the draft text as of April 2016, prior to the start of the 13th round of TTIP negotiations between the EU and the US (New York, 25-29 April 2016). As far as we know the final document will consist of 25 to 30 chapters and many extensive annexes. The EU Commission published an overview stating that they have now 17 consolidated texts. This means the documents released by Greenpeace Netherlands encompass 3/4 of the existing consolidated texts.[1]
Consolidated texts are those where the EU and US positions on issues are shown side by side. This step in the negotiation process allows us to see the areas where the EU and US are close to agreement, and where compromises and concessions would still need to be made. Of the documents released by Greenpeace Netherlands, in total 248 pages, 13 chapters offer for the first time the position of the US.
How have the documents been handled?
The documents we received had clearly been treated to make it possible to identify individual copies. Prior to release they have been retyped and identifying features removed. We have not altered content of the documents and have preserved the layout. For this reason we are not offering access to the original documents.
How do you know the documents are genuine?
After receiving the documents both Greenpeace Netherlands and Rechercheverbund NDR, WDR und Suddeutsche Zeitung, a renowned German investigative research partnership have analysed them and compared them to existing documents. The Rechercheverbund, which consists of different German media outlets, has covered, amongst other big stories, the Snowden leaks and the recent Volkswagen emissions scandals.
What are the first conclusions from the documents?
From an environmental and consumer protection point of view four aspects are of serious concern.
Long standing environmental protections appear to be dropped
None of the chapters we have seen reference the General Exceptions rule. This nearly 70-year-old rule enshrined in the GATT agreement of the World Trade Organization (WTO), allows nations to regulate trade "to protect human, animal and plant life or health" or for "the conservation of exhaustible natural resources" [2]. The omission of this regulation suggests both sides are creating a regime that places profit ahead of human, animal and plant life and health.
Climate protection will be harder under TTIP
The Paris Climate Agreement makes one point clear: We must keep temperature increase under 1.5 degrees to avoid a climate crisis with effects on billions of people worldwide. Trade should not be excluded from climate action. But nothing indicating climate protection can be found in the obtained texts. Even worse, the scope for mitigation measures is limited by provisions of the chapters on Regulatory Cooperation or Market Access for Industrial Goods. [3] As an example these proposals would rule out regulating the import of CO2 intensive fuels such as oil from Tar Sands.
The end of the precautionary principle
The precautionary principle, enshrined in the EU Treaty[4], is not mentioned in the chapter on Regulatory Cooperation, nor in any other of the obtained 12 chapters. On the other hand the US demand for a 'risk based' approach that aims to manage hazardous substances rather than avoid them, finds its way into various chapters. This approach undermines the ability of regulators to take preventive measures, for example regarding controversial substances like hormone disrupting chemicals.
Opening the door for corporate takeover
While the proposals threaten environmental and consumer protection, big business gets what it wants. Opportunities to participate in decision making are granted to corporations to intervene at the earliest stages of the decision making process.
While civil society has had little access to the negotiations, there are many instances where the papers show that industry has been granted a privileged voice in important decisions. [5] The leaked documents indicate that the EU has not been open about the high degree of industry influence. The EU's recent public report [6] has only one minor mention of industry input, whereas the leaked documents repeatedly talk about the need for further consultations with industry and explicitly mention how industry input has been collected.
###
Notes:
[1] The documents we are releasing are
[chapter 1.1.] National Treatment and Market Access for Goods
This chapter addresses trade in goods between EU and US.
[chapter 1.2.] Agriculture
This chapter deals with trade in agricultural products and illustrates EU-US disagreements on matters such as genetically modified organisms.
[chapter 1.3.] Cross-Border Trade in Services
This chapter addresses trade in the service industry sector.
[chapter 1.4] Electronic Communications
This chapter addresses Internet and telecommunications issues.
[chapter 1.5.] Government Procurement
This chapter deals with purchases by government entities within the EU and US.
[chapter 1.6.] Annex Government Procurement
The annex of the previous chapter, with additional information about a US-proposed chapter on anti-corruption.
[chapter 1.7.] Customs and Trade and Facilitation
This chapter addresses differences among various customs regulations.
[chapter 1.8.] EU - US revised tariff offers
These are the respective positions regarding tariffs.
[chapter 2.1.] Regulatory Cooperation
In this controversial chapter EU and US aim for joint regulations on products and services, for example for food and cosmetics safety.
[chapter 2.2.] Technical Barriers to Trade
This chapter addresses differences between EU-US regulations and the ways in which they affect trade.
[chapter 2.3.] Sanitary and Phytosanitary Measures
This chapter deals with the protection of plant and animal health.
[chapter 3.1.] Competition
This chapter deals with competition between parties.
[chapter 3.2.] Small and Medium-sized Enterprise
This chapter addresses enterprises smaller than multi-national corporations.
[chapter 3.3.] State-owned Enterprise
This chapter addresses nationalised enterprises.
[chapter 4.] Dispute Settlement
This chapter deals with resolving disagreements between the EU and the US.
[chapter 5.] Tactical State of Play
Not intended for public viewing, this document describes EU-US disagreements and shows how much private industry influences the TTIP negotiations.
[2] Most of the WTO's agreements were the outcome of the 1986-94 Uruguay Round of trade negotiations. Some, including GATT 1994, were revisions of texts that previously existed.
[3] Nothing in the relevant Articles 10 (Import and Export Restrictions) and 12 (Import and Export Licensing) of the Chapter on National Treatment and Market Access for Goods shows that necessary trade related measures to protect the climate would be allowed as a trade restriction under GATT Article XX (see footnote 1).
[4] "The precautionary principle is detailed in Article 191 of the Treaty on the Functioning of the European Union (EU). It aims at ensuring a higher level of environmental protection through preventative decision-taking in the case of risk. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=URISERV%3Al32042
[5] e.g. "While the US showed an interest, it hastened to point out that it would need to consult with its industry regarding some of the products" - Chapter 'Tactical State of Play', paragraph 1.1, Agriculture.
[6] 'The Twelfth Round of Negotiations for the Transatlantic Trade and Investment Partnership (TTIP)' https://trade.ec.europa.eu/doclib/docs/2016/march/tradoc_154391.pdf
Greenpeace is a global, independent campaigning organization that uses peaceful protest and creative communication to expose global environmental problems and promote solutions that are essential to a green and peaceful future.
+31 20 718 2000LATEST NEWS
Senate Tosses 'Dangerous Provision' Preventing State-Level AI Regulation From GOP Megabill
"From the start, this provision had Big Tech's money and lobbyists all over it. This is a major victory for the American people over the AI industry," said one advocate.
Jul 01, 2025
With a 99-1 vote early Tuesday, the Republican-controlled Senate decided to remove a controversial provision that would have prevented state-level regulation on artificial intelligence for 10 years from U.S. President Donald Trump's massive tax and spending bill that is currently being debated in Congress.
Sen. Thom Tillis (R-N.C.) was the lone lawmaker who voted to keep the moratorium in the bill.
While far from the only controversial part of the reconciliation package, the provision drew opposition from an ideologically diverse group that included Democratic and Republican state attorneys general; over 140 groups working to support children's online safety, consumer protections, and responsible innovation; and faith leaders.
Senators struck Sen. Ted Cruz's (R-Texas) AI measure from the megabill by adopting an amendment introduced by Sen. Marsha Blackburn (R-Tenn.). They voted on Blackburn's amendment during a session known as a vote-a-rama. Blackburn introduced the amendment after considering an agreement that would have watered down the provision.
According to The Verge, the measure that was rejected on Tuesday required states to avoid regulation AI and "automated decision systems" if they wanted to get funding for their broadband programs.
The provision would have been a major win for Big Tech, which has made the case that state laws around AI are obstructing their ability to do business.
Advocates and Democratic lawmakers cheered the decision to strip the provision.
"From the start, this provision had Big Tech's money and lobbyists all over it. This is a major victory for the American people over the AI industry. It shows that Americans are aware of the proliferation of AI harms in real time," said J.B. Branch, Big Tech accountability advocate at the watchdog group Public Citizen.
Sen. Edward Markey (D-Mass.) said Tuesday that "early this morning, the Senate overwhelmingly voted to reject a dangerous provision to block states from regulating artificial intelligence, including protecting kids online. This 99-1 vote sent a clear message that Congress will not sell out our kids and local communities in order to pad the pockets of Big Tech billionaires."
In addition to concerns focused on Big Tech, experts recently told The Guardian that in the absence of state-level AI regulation, untrammeled growth of AI would take a toll on the world's "dangerously overheating climate."
Sacha Haworth, the executive director of the Tech Oversight Project, credited the "massive" defeat of Cruz's provision to the "incredible mobilizing by advocates to beat back Big Tech lobbying and last-minute bullying."
Keep ReadingShow Less
Critics Shred JD Vance as He Shrugs Off Millions of Americans Losing Medicaid as 'Minutiae'
"What happened to you J.D. Vance—author of Hillbilly Elegy—now shrugging off Medicaid cuts that will close rural hospitals and kick millions off healthcare as 'minutiae?'" asked Rep. Ro Khanna (D-Calif.).
Jul 01, 2025
Vice President J.D. Vance took heat from critics this week when he downplayed legislation that would result in millions of Americans losing Medicaid coverage as mere "minutiae."
Writing on X, Vance defended the budget megabill that's currently being pushed through the United States Senate by arguing that it will massively increase funding to Immigration and Customs Enforcement, which he deemed to be a necessary component of carrying out the Trump administration's mass deportation operation.
"The thing that will bankrupt this country more than any other policy is flooding the country with illegal immigration and then giving those migrants generous benefits," wrote Vance. "The [One Big Beautiful Bill] fixes this problem. And therefore it must pass."
He then added that "everything else—the CBO score, the proper baseline, the minutiae of the Medicaid policy—is immaterial compared to the ICE money and immigration enforcement provisions."
It was this line that drew the ire of many critics, as the Congressional Budget Office has estimated that the Senate version of the budget bill would slash spending on Medicaid and the Children's Health Insurance Program by more than $1 trillion over a ten-year-period, which would result in more than 10 million people losing their coverage. Additionally, Sen. Rick Scott (R-Fla.) has proposed an amendment that would roll back the expansion of Medicaid under the 2010 Affordable Care Act, which would likely kick millions more off of the program.
Many congressional Democrats were quick to pounce on Vance for what they said were callous comments about a vital government program.
"So if the only thing that matters is immigration... why didn't you support the bipartisan Lankford-Murphy bill that tackled immigration far better than your Ugly Bill?" asked Rep. Daniel Goldman (D-N.Y.). "And it didn't have 'minutiae' that will kick 12m+ Americans off healthcare or raise the debt by $4tn."
"What happened to you J.D. Vance—author of Hillbilly Elegy—now shrugging off Medicaid cuts that will close rural hospitals and kick millions off healthcare as 'minutiae?'" asked Rep. Ro Khanna (D-Calif.).
Veteran healthcare reporter Jonathan Cohn put some numbers behind the policies that are being minimized by the vice president.
"11.8M projected to lose health insurance," he wrote. "Clinics and hospitals taking a hit, especially in rural areas. Low-income seniors facing higher costs. 'Minutiae.'"
Activist Leah Greenberg, the co-chair of progressive organizing group Indivisible, zeroed in on Vance's emphasis on ramping up ICE's funding as particularly problematic.
"They are just coming right out and saying they want an exponential increase in $$$ so they can build their own personal Gestapo," she warned.
Washington Post global affairs columnist Ishaan Tharoor also found himself disturbed by the sheer size of the funding increase for ICE that Vance is demanding and he observed that "nothing matters more apparently than giving ICE a bigger budget than the militaries of virtually every European country."
Keep ReadingShow Less
'Heinrich Should Be Ashamed': Lone Senate Dem Helps GOP Deliver Big Pharma Win
The provision, part of the Senate budget bill, was described as "a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients while draining $5 billion in taxpayer dollars."
Jul 01, 2025
The deep-pocketed and powerful pharmaceutical industry notched a significant victory on Monday when the Senate parliamentarian ruled that a bill described by critics as a handout to drug corporations can be included in the Republican reconciliation package, which could become law as soon as this week.
The legislation, titled the Optimizing Research Progress Hope and New (ORPHAN) Cures Act, would exempt drugs that treat more than one rare disease from Medicare's drug-price negotiation program, allowing pharmaceutical companies to charge exorbitant prices for life-saving medications in a purported effort to encourage innovation. (Medications developed to treat rare diseases are known as "orphan drugs.")
The consumer advocacy group Public Citizen observed that if the legislation were already in effect, Medicare "would have been barred from negotiating lower prices for important treatments like cancer drugs Imbruvica, Calquence, and Pomalyst."
Among the bill's leading supporters is Sen. Martin Heinrich (D-N.M.), whose spokesperson announced the parliamentarian's decision to allow the measure in the reconciliation package after previously advising that it be excluded. Heinrich is listed as the legislation's only co-sponsor in the Senate, alongside lead sponsor Sen. John Barrasso (R-Wyo.).
"Sen. Heinrich should be ashamed of prioritizing drug corporation profits over lower medicine prices for seniors and people with disabilities," Steve Knievel, access to medicines advocate at Public Citizen, said in a statement Monday. "Patients and consumers breathed a sigh of relief when the Senate parliamentarian stripped the proposal from Republicans' Big Ugly Betrayal, so it comes as a gut punch to hear that Sen. Heinrich welcomed the reversal and continued to champion a proposal that will transfer billions from taxpayers to Big Pharma."
"People across the country are demanding lower drug prices and for Medicare drug price negotiations to be expanded, not restricted," Knievel added. "Sen. Heinrich should apologize to his constituents and start listening to them instead of drug corporation lobbyists."
The Biotechnology Innovation Organization, a lobbying group whose members include pharmaceutical companies, has publicly endorsed and promoted the legislation, urging lawmakers to pass it "as soon as possible."
"This is a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients."
The nonpartisan Congressional Budget Office has estimated that the ORPHAN Cures Act would cost U.S. taxpayers around $5 billion over the next decade.
Merith Basey, executive director of Patients For Affordable Drugs Now, said that "patients are infuriated to see the Senate cave to Big Pharma by reviving the ORPHAN Cures Act at the eleventh hour."
"This is a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients while draining $5 billion in taxpayer dollars," said Basey. "We call on lawmakers to remove this unnecessary provision immediately and stand with an overwhelming majority of Americans who want the Medicare Negotiation program to go further. Medicare negotiation will deliver huge savings for seniors and taxpayers; this bill would undermine that progress."
Keep ReadingShow Less
Most Popular